Last reviewed · How we verify

H.P. Acthar Gel — Competitive Intelligence Brief

H.P. Acthar Gel (H.P. Acthar Gel) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticotropin (ACTH analog). Area: Immunology / Rheumatology.

marketed Corticotropin (ACTH analog) Melanocortin-2 receptor (MC2R) Immunology / Rheumatology Small molecule Live · refreshed every 30 min

Target snapshot

H.P. Acthar Gel (H.P. Acthar Gel) — Fiechtner, Justus J., M.D., P.C.. H.P. Acthar Gel is a corticotropin (ACTH) preparation that stimulates the adrenal cortex to produce and release cortisol and other corticosteroids.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
H.P. Acthar Gel TARGET H.P. Acthar Gel Fiechtner, Justus J., M.D., P.C. marketed Corticotropin (ACTH analog) Melanocortin-2 receptor (MC2R)
Open label H.P. Acthar Gel Open label H.P. Acthar Gel Fiechtner, Justus J., M.D., P.C. marketed Corticotropin (ACTH analog) Melanocortin-2 receptor (MC2R)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticotropin (ACTH analog) class)

  1. Fiechtner, Justus J., M.D., P.C. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). H.P. Acthar Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/h-p-acthar-gel. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: